JESSICA GARCIA: Open Payments
NPI 1124321096 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,009 in 45 payments from 15 companies in 2025. Trend: 2023 $1,274 · 2024 $1,141 · 2025 $1,009
Food & beverage: $1,009
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $180 |
| Otsuka America Pharmaceutical, Inc. | 11 | $173 |
| GlaxoSmithKline, LLC. | 6 | $130 |
| Lilly USA, LLC | 4 | $89 |
| ABBVIE INC. | 4 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63 |
| Abbott Laboratories | 1 | $51 |
| AtriCure, Inc. | 2 | $49 |
| PFIZER INC. | 2 | $47 |
| Novo Nordisk Inc | 2 | $36 |
Products named: FARXIGA, REXULTI, JARDIANCE, TRELEGY ELLIPTA, LINZESS, PROCLAIM, ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM, ELIQUIS.
Industry payments across TX — which companies pay providers there.
